KWF
Lead4Life PPP Call 2026
12:00 noon; full proposal phase. Matchmaking phase precedes full proposal submission.
Last verified:
Details
| Funder | KWF |
| Budget | €0.5M–€2M per project (total programme: €5M) |
| Deadline | 22 September 2026 |
| Duration | Up to 4 years |
| Consortium | Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory |
| Application | 2-stage: matchmaking phase → full proposal (deadline 22 September 2026) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Health~Holland PPP programme focused on lead-212 (Pb-212) radiopharmaceuticals for cancer treatment. Two pillars: (1) Pb-212 production & supply chain; (2) enabling technologies for clinical introduction. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Consortium Agreement required. Submission via KWF GMS; unregistered institutes must register ≥6 weeks before deadline.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies
Deadline: 18 Jun 2026Up to €3MBOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)
Deadline: 1 Jul 2026~€150,000 per projectBoost-2026
Deadline: 7 Jul 2026KWF Pipeline Call 2026
Deadline: 7 Jul 2026€1M-€5MPipeline
Deadline: 7 Jul 2026€1–5M
Browse Related
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free